ASCO

Career Opportunities

Multiple Oncology Opportunities Available Now
Provider Solutions & Development (Portland, OR, Santa Monica, CA, Binghamton, NY, Kennewick, WA, Lubbock, TX)

Multiple Oncology positions are available now at Provider Solutions and Development for both experienced physicians and new graduates.

Established Programs Coast-to-Coast; Fellowship Stipend + Benefits
LifePoint Health (Alabama, Arizona, Montana, New Mexico, Pennsylvania, Tennessee, Virginia)

LifePoint Health, a national healthcare system, has need for Hematologist/Oncologists at multiple hospitals.

Cleveland Clinic Florida - Hematologist/Oncologist
Cleveland Clinic Martin Health (Stuart, Florida)

The Cleveland Clinic Florida Cancer Institute is currently seeking highly skilled and qualified medical hematologist/oncologists.

Latest Issue of Journal of Clinical Oncology Now Available

IN MEMORIAM

Joseph R. Bertino, Scientist and Clinical Oncologist
Chabner et al.

EDITORIALS

Testing for High-Risk Human Papillomavirus in Lower Genital Tract Tumors: If Knowledge Does Not Translate to an Action That Helps Patients—Why Do It?
Moore et al.

COMMENTS AND CONTROVERSIES

Controlling the Control Arm in Metastatic Castration-Resistant Prostate Cancer Trials: Best Standard of Care or the Minimum Standard of Care?
Wambeke et al.

ORIGINAL REPORTS

Human Papillomavirus Infection Determines Prognosis in Cervical Cancer
Lei et al.

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
Li et al.

Predicting the Likelihood of Carrying a BRCA1 or BRCA2 Mutation in Asian Patients With Breast Cancer
Ang et al.

Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F
Damodaran et al.

Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine–DNA Methyltransferase–Silenced Metastatic Colorectal Cancer: The MAYA Trial
Morano et al.

SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome–Negative B-Cell Acute Lymphoblastic Leukemia
Advani et al.

Minority Enrollment in Phase II and III Clinical Trials in Urologic Oncology
Owens-Walton et al.

UNDERSTANDING THE PATHWAY

Germline Pathogenic Variants in BRCA1 and BRCA2: Malignancies Beyond Female Breast and Ovarian Cancers
Lieberman et al.

CORRESPONDENCE

Ductal Carcinoma In Situ and Breast Cancer Overdiagnosis
Jatoi et al.

Reply to I. Jatoi
Wright et al.

Frontline Dual Checkpoint Inhibition in Metastatic Melanoma Over Anti–PD-1 Monotherapy: The Case for a Comparative Randomized Controlled Trial
Olivier et al.

Reply to T. Olivier et al
Wolchok et al.

Updates From ASCO

Frontiers in Cancer Immunotherapy, May 9 -11, NYC
Join the New York Academy of Sciences for their 9th annual Frontiers in Cancer Immunotherapy, a convening of immuno-oncology experts sharing cutting-edge discoveries. This event is virtual and in-person in NYC. Topics to be covered at this symposium include modulation of the tumor microenvironment; targeting tumor resistance; therapeutic potential of cytokines; combination therapy; and computational bioinformatics. Visit the event agenda page for the full list of lectures and speakers. Register now.

Sign up for ASCO Daily News Emails
Don’t miss the latest oncology news and commentary. Opt-in now.

JCO After Hours: A Discussion With Veena Shankaran and Scott Ramsey
Shannon Westin, Veena Shankaran, and Scott Ramsey discuss their article about financial toxicity and the impact of cancer diagnosis on patients' credit standing. Listen now.

JCO's Cancer Stories: The Art of Oncology
"Questions for the Oncologist," by Barry Meisenberg: an oncologist struggles to answer a patient’s “Why me?” question. Listen now.

Manage your preferences for
ASCO Journals email alerts

American Society of Clinical Oncology
2318 Mill Road, Suite 800
Alexandria, VA 22314
USA
571-483-1300
ASCO.org • ascopubs.org

Unsubscribe